Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousGranulocyte Colony-Stimulating FactorLeukapheresisStem CellsMelphalanAntigens, CD34Blood Component RemovalHematologic NeoplasmsHematopoietic Stem CellsCombined Modality TherapyStem Cell TransplantationCyclophosphamideMultiple MyelomaGraft vs Host DiseaseAntineoplastic Combined Chemotherapy ProtocolsBusulfanMyeloablative AgonistsBone Marrow TransplantationGraft SurvivalTreatment OutcomeLymphoma, Non-HodgkinEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceAdult Stem CellsEmbryonic Stem CellsIfosfamideCord Blood Stem Cell TransplantationCarmustineHematopoiesisCytophagocytosisSalvage TherapyVincristineAmyloidosisCytarabineTissue DonorsTransplantation ChimeraDisease-Free SurvivalHodgkin DiseaseRetrospective StudiesNeoplasmsWhole-Body IrradiationSurvival RateInfectionBlood Cell CountHistocompatibilityBlood CellsTime FactorsCell DifferentiationPlatelet CountPOEMS SyndromeSurvival AnalysisHistocompatibility TestingDoxorubicinLymphoma, T-CellImmunosuppressive AgentsVidarabineTransplantation, IsogeneicCarboplatinLeukemia, Myeloid, AcuteBone Marrow PurgingLeukemiaRecombinant ProteinsPrednisoneDexamethasoneLymphomaFollow-Up StudiesCytomegalovirus InfectionsFeasibility StudiesAntineoplastic AgentsGraft vs Leukemia EffectImmunophenotypingProspective StudiesFatal OutcomeBlood DonorsAnemia, AplasticLeukocytes, MononuclearCell SeparationMesenchymal Stem Cell TransplantationMyelodysplastic SyndromesBone MarrowLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionPluripotent Stem CellsFlow CytometryT-LymphocytesHematologic DiseasesHistiocytosis, Non-Langerhans-CellImmunomagnetic SeparationCells, CulturedBone Marrow DiseasesOpportunistic InfectionsAntigens, CD